Cpr Investments Inc. Moderna, Inc. Transaction History

Cpr Investments Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $4,919 - $7,416	42 Added 2.93%	1,475 $211,000
Q1 2022 May 06, 2022	BUY	$126.46 - $235.05 $40,340 - $74,980	319 Added 28.64%	1,433 $247,000
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $251,563 - $410,520	1,114 New	1,114 $283,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Cpr Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Cpr Investments Inc. with notifications on news.